Cipher Pharmaceuticals's market cap is currently ―. The company's EPS TTM is C$1.111; its P/E ratio is 7.93; Cipher Pharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is C$0.14. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 4.92M	$ 6.07M	$ 5.29M	$ 4.89M	$ 8.42M
Gross Profit	$ 3.96M	$ 4.99M	$ 4.23M	$ 3.91M	$ 7.49M
EBIT	$ 2.39M	$ 7.15M	$ 3.17M	$ 2.71M	$ 6.18M
EBITDA	$ 2.67M	$ 7.42M	$ 3.51M	$ 3.05M	-
Net Income Common Stockholders	$ 7.66M	$ 7.03M	$ 3.07M	$ 2.63M	$ 23.19M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 39.83M	$ 42.09M	$ 36.34M	$ 33.43M	$ 28.84M
Total Assets	$ 86.03M	$ 90.53M	$ 80.61M	$ 76.96M	$ 73.78M
Total Debt	$ 353.00K	$ 353.00K	$ 386.00K	$ 403.00K	$ 428.00K
Net Debt	$ -39.47M	$ -41.73M	$ -35.95M	$ -33.02M	$ -28.41M
Total Liabilities	$ 5.51M	$ 12.98M	$ 10.41M	$ 9.82M	$ 9.70M
Stockholders Equity	$ 80.52M	$ 77.55M	$ 70.20M	$ 67.14M	$ 64.08M
Cash Flow	-
Free Cash Flow	$ 2.27M	$ 5.97M	$ 2.95M	$ 4.67M	$ 1.47M
Operating Cash Flow	$ 2.42M	$ 5.97M	$ 2.95M	$ 4.67M	$ 1.47M
Investing Cash Flow	$ -144.00K	-	-	-	-
Financing Cash Flow	$ -4.94M	$ -27.00K	$ -242.00K	$ -34.00K	$ -189.00K

Currency in USD

Cipher Pharmaceuticals Earnings and Revenue History

Income Statement >

Cipher Pharmaceuticals Debt to Assets

Balance Sheet >

Cipher Pharmaceuticals Cash Flow

Cash Flow >

Cipher Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing